smylp的个人主页 - 老虎社区

smylp

smylp

暂无个人介绍

IP属地：未知

132关注

12粉丝

0主题

0勋章

2021-11-24

What

Musk Has Now Sold More Than Half the Stock He Vowed on Twitter

2021-11-24

$Senseonics(SENS)$when is result coming out?

2021-11-12

$Recon Technology(RCON)$useless sia

2021-11-01

$Orphazyme A/S(ORPH)$so is this good news????

2021-11-01

???? Going to delist???

抱歉，原内容已删除

2021-09-24

$SOS Limited(SOS)$Jialat

2021-09-15

How does option works?? No clue

@鑫鑫鑫鑫鑫鑫鑫:$TIGR 20211015 20.0 CALL(TIGR)$我开始膨胀了，只要我期权卖的多，亏损就追不上我

2021-09-08

$Effector Therapeutics, Inc.(EFTR)$ah didn't saw this rise

2021-08-26

$Effector Therapeutics, Inc.(EFTR)$wth

2021-08-23

$Senseonics(SENS)$ggoing where...

2021-08-20

$Recon Technology(RCON)$will it go up??

2021-08-12

Oh

抱歉，原内容已删除

2021-08-03

Ok

This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine

2021-07-30

$Atossa Genetics(ATOS)$wwowoww drop till no where???

2021-07-27

$Atossa Genetics(ATOS)$rubbish sia

2021-07-23

Up

@Gold75:$Atossa Genetics(ATOS)$up up up

2021-07-23

O

EV stocks fell in morning trading

2021-07-20

O

Behind The Plunge In Yields: This Is A Growth Story, Not A Rethink Of Inflation

2021-07-16

$Atossa Genetics(ATOS)$what the. Why????

2021-07-12

$Exela Technologies, Inc.(XELA)$wow

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3571128564126664","uuid":"3571128564126664","gmtCreate":1608035803038,"gmtModify":1611671284957,"name":"smylp","pinyin":"smylp","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":12,"headSize":132,"tweetSize":93,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.90%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.52%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":874951015,"gmtCreate":1637722665703,"gmtModify":1637722665829,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"What","listText":"What","text":"What","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874951015","repostId":"1178572049","repostType":2,"repost":{"id":"1178572049","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637721621,"share":"https://www.laohu8.com/m/news/1178572049?lang=&edition=full","pubTime":"2021-11-24 10:40","market":"us","language":"en","title":"Musk Has Now Sold More Than Half the Stock He Vowed on Twitter","url":"https://stock-news.laohu8.com/highlight/detail?id=1178572049","media":"Tiger Newspress","summary":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfwa","content":"<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Has Now Sold More Than Half the Stock He Vowed on Twitter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Has Now Sold More Than Half the Stock He Vowed on Twitter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-24 10:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178572049","content_text":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.\nThe billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.\nWith the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.\n\nTo reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.\nMusk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.\nMusk, 50, is the world’s richest person with a $303.7 billion fortune, according to the Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":608,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875738339,"gmtCreate":1637684321842,"gmtModify":1637684321966,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>when is result coming out?","listText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>when is result coming out?","text":"$Senseonics(SENS)$when is result coming out?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875738339","isVote":1,"tweetType":1,"viewCount":2467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870780360,"gmtCreate":1636647226321,"gmtModify":1636668596492,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RCON\">$Recon Technology(RCON)$</a>useless sia","listText":"<a href=\"https://laohu8.com/S/RCON\">$Recon Technology(RCON)$</a>useless sia","text":"$Recon Technology(RCON)$useless sia","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870780360","isVote":1,"tweetType":1,"viewCount":2038,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849213291,"gmtCreate":1635757995675,"gmtModify":1635757995799,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ORPH\">$Orphazyme A/S(ORPH)$</a>so is this good news????","listText":"<a href=\"https://laohu8.com/S/ORPH\">$Orphazyme A/S(ORPH)$</a>so is this good news????","text":"$Orphazyme A/S(ORPH)$so is this good news????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849213291","isVote":1,"tweetType":1,"viewCount":619,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849293554,"gmtCreate":1635756900053,"gmtModify":1635756900170,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"???? Going to delist???","listText":"???? Going to delist???","text":"???? Going to delist???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849293554","repostId":"849207895","repostType":1,"isVote":1,"tweetType":1,"viewCount":805,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861283475,"gmtCreate":1632497770397,"gmtModify":1632715611900,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOS\">$SOS Limited(SOS)$</a>Jialat","listText":"<a href=\"https://laohu8.com/S/SOS\">$SOS Limited(SOS)$</a>Jialat","text":"$SOS Limited(SOS)$Jialat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/861283475","isVote":1,"tweetType":1,"viewCount":710,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":882418153,"gmtCreate":1631714319072,"gmtModify":1631889848630,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"How does option works?? No clue","listText":"How does option works?? No clue","text":"How does option works?? No clue","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882418153","repostId":"882419118","repostType":1,"repost":{"id":882419118,"gmtCreate":1631714182334,"gmtModify":1631714182334,"author":{"id":"3508855846268996","authorId":"3508855846268996","name":"鑫鑫鑫鑫鑫鑫鑫","avatar":"https://static.tigerbbs.com/52afbe623999c99de80e0cb385aca290","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3508855846268996","authorIdStr":"3508855846268996"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$TIGR 20211015 20.0 CALL(TIGR)$</a>我开始膨胀了，只要我期权卖的多，亏损就追不上我","listText":"<a href=\"https://laohu8.com/S/TIGR\">$TIGR 20211015 20.0 CALL(TIGR)$</a>我开始膨胀了，只要我期权卖的多，亏损就追不上我","text":"$TIGR 20211015 20.0 CALL(TIGR)$我开始膨胀了，只要我期权卖的多，亏损就追不上我","images":[{"img":"https://static.tigerbbs.com/ef577206192474bbf239bac2f239dd0a","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882419118","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880594808,"gmtCreate":1631064032304,"gmtModify":1631885500911,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/EFTR\">$Effector Therapeutics, Inc.(EFTR)$</a>ah didn't saw this rise","listText":"<a href=\"https://laohu8.com/S/EFTR\">$Effector Therapeutics, Inc.(EFTR)$</a>ah didn't saw this rise","text":"$Effector Therapeutics, Inc.(EFTR)$ah didn't saw this rise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/880594808","isVote":1,"tweetType":1,"viewCount":284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810549478,"gmtCreate":1629988271894,"gmtModify":1704954268629,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/EFTR\">$Effector Therapeutics, Inc.(EFTR)$</a>wth","listText":"<a href=\"https://laohu8.com/S/EFTR\">$Effector Therapeutics, Inc.(EFTR)$</a>wth","text":"$Effector Therapeutics, Inc.(EFTR)$wth","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810549478","isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835489523,"gmtCreate":1629731670062,"gmtModify":1631884679317,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>ggoing where...","listText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>ggoing where...","text":"$Senseonics(SENS)$ggoing where...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/835489523","isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836633949,"gmtCreate":1629474110381,"gmtModify":1631888732010,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RCON\">$Recon Technology(RCON)$</a>will it go up??","listText":"<a href=\"https://laohu8.com/S/RCON\">$Recon Technology(RCON)$</a>will it go up??","text":"$Recon Technology(RCON)$will it go up??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/836633949","isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894095673,"gmtCreate":1628776881292,"gmtModify":1631889848637,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894095673","repostId":"2158251366","repostType":2,"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807912214,"gmtCreate":1627996160538,"gmtModify":1631889848653,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807912214","repostId":"2156147918","repostType":4,"repost":{"id":"2156147918","kind":"highlight","pubTimestamp":1627994460,"share":"https://www.laohu8.com/m/news/2156147918?lang=&edition=full","pubTime":"2021-08-03 20:41","market":"us","language":"en","title":"This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2156147918","media":"Motley Fool","summary":"Pfizer might not have to wait very long for this product to hit the market.","content":"<p>In 2019 and 2020,&nbsp;<b>Pfizer</b>'s (NYSE:PFE) top-selling product was pneumococcal vaccine Prevnar 13. It generated over $5.8 billion in sales in both years. That's a lot of money for a very successful product.</p>\n<p>But Prevnar 13 is no longer Pfizer's top-selling product. The COVID-19 vaccine BNT162b2, developed by Pfizer and <b>BioNTech</b> (NASDAQ:BNTX), generated sales of $7.8 billion in the first half of 2021 alone. Pfizer expects the vaccine will rake in $33.5 billion over the entire year. Even with the company splitting profits with BioNTech, Pfizer should conservatively make in the ballpark of $17 billion from BNT162b2 this year.</p>\n<p>Even more money could be on the way. Pfizer is busy working on its next potential COVID-19 blockbuster -- and it isn't a vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/2e39eb3485964eb8dab974f72921be8b\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Stopping the coronavirus in its tracks</h3>\n<p>Pfizer has stated for a while that it wouldn't restrict its efforts to fight COVID-19 to only vaccines. It has also focused on developing potential treatments for the infectious disease. The company provided an update on <a href=\"https://laohu8.com/S/AONE.U\">one</a> especially promising therapy in its second-quarter conference call last week.</p>\n<p>Protease inhibitors are a class of antiviral drugs that have been effective in treating HIV and hepatitis C. These therapies bind to protease enzymes in viruses and prevent the virus from replicating.</p>\n<p>Pfizer initiated an early stage clinical study evaluating oral protease inhibitor PF-07321332 in March of this year. The company had good news to report from that study in its Q2 update.</p>\n<p>Chief scientific officer Mikael Dolsten said that in the phase 1 study, PF-07321332 exceeded the level predicted to inhibit coronavirus viral replication by more than fivefold. Dolsten also stated that the experimental protease inhibitor showed powerful antiviral activity in preclinical testing that could be effective against \"all currently known COVID-19 variants.\"</p>\n<p>So far, the experimental antiviral drug appears to have a good safety profile. Dolsten said that there haven't been any safety issues in giving doses of up to 500 milligrams twice per day over a 10-day period.</p>\n<p>Based on these encouraging results, Pfizer advanced the oral protease inhibitor into phase 2/3 testing in July. The company will evaluate PF-07321332 in five-day and 10-day treatments for individuals who have been in close contact with someone with COVID-19.</p>\n<h3>A big market opportunity</h3>\n<p>Pfizer estimates that the addressable market for its protease inhibitor could be in the hundreds of millions of patients. That doesn't seem farfetched considering the rapid spread of COVID-19 exposure due to the delta variant.</p>\n<p>The U.S. Food and Drug Administration (FDA) has already granted Emergency Use Authorization (EUA) to <b>Regeneron</b>'s (NASDAQ:REGN) antibody cocktail REGEN-COV as a treatment for hospitalized COVID-19 patients and for post-exposure prophylaxis. However, there are a few drawbacks to Regeneron's therapy.</p>\n<p>First, REGEN-COV is expensive -- more than $2,000 per dose. Second, it must be administered via infusion or subcutaneous injection. Third, the current U.S. EUA for post-exposure prophylaxis only applies to individuals who have been exposed to COVID-19 who have a high risk of developing COVID-19 and who haven't been fully vaccinated.</p>\n<p>Pfizer's PF-07321332 would be much more convenient than REGEN-COV since it's taken orally. Although the big drugmaker hasn't given any hints about what the pricing for the antiviral therapy might be should it win EUA or approval, a lower price tag could open up a wide market that might include lower-risk individuals who are exposed to COVID-19.</p>\n<h3>Coming soon?</h3>\n<p>There shouldn't be a long wait for Pfizer's next potential COVID-19 blockbuster. Assuming the phase 2/3 testing goes well, the company thinks that it will be able to file for U.S. EUA in the fourth quarter of this year.</p>\n<p>Pfizer CEO Albert Bourla said in the company's Q2 call that he's given the green light to manufacture \"significant quantities\" of the oral protease inhibitor so that large volumes of doses will be available if EUA is granted. He added that Pfizer is absorbing the risk of making this investment because \"it is the right thing to do.\"</p>\n<p>PF-07321332 probably won't be as big a catalyst for the big pharma stock as the Pfizer-BioNTech COVID-19 vaccine. However, Pfizer won't have to split the profits on the oral therapy as it does with BNT162b2. If the company's late-stage testing of the COVID-19 drug is successful, Pfizer seems very likely to have another blockbuster on its hands in 2022.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-03 20:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/03/this-could-be-pfizers-next-covid-blockbuster-and-i/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In 2019 and 2020, Pfizer's (NYSE:PFE) top-selling product was pneumococcal vaccine Prevnar 13. It generated over $5.8 billion in sales in both years. That's a lot of money for a very successful ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/03/this-could-be-pfizers-next-covid-blockbuster-and-i/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/08/03/this-could-be-pfizers-next-covid-blockbuster-and-i/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156147918","content_text":"In 2019 and 2020, Pfizer's (NYSE:PFE) top-selling product was pneumococcal vaccine Prevnar 13. It generated over $5.8 billion in sales in both years. That's a lot of money for a very successful product.\nBut Prevnar 13 is no longer Pfizer's top-selling product. The COVID-19 vaccine BNT162b2, developed by Pfizer and BioNTech (NASDAQ:BNTX), generated sales of $7.8 billion in the first half of 2021 alone. Pfizer expects the vaccine will rake in $33.5 billion over the entire year. Even with the company splitting profits with BioNTech, Pfizer should conservatively make in the ballpark of $17 billion from BNT162b2 this year.\nEven more money could be on the way. Pfizer is busy working on its next potential COVID-19 blockbuster -- and it isn't a vaccine.\n\nImage source: Getty Images.\nStopping the coronavirus in its tracks\nPfizer has stated for a while that it wouldn't restrict its efforts to fight COVID-19 to only vaccines. It has also focused on developing potential treatments for the infectious disease. The company provided an update on one especially promising therapy in its second-quarter conference call last week.\nProtease inhibitors are a class of antiviral drugs that have been effective in treating HIV and hepatitis C. These therapies bind to protease enzymes in viruses and prevent the virus from replicating.\nPfizer initiated an early stage clinical study evaluating oral protease inhibitor PF-07321332 in March of this year. The company had good news to report from that study in its Q2 update.\nChief scientific officer Mikael Dolsten said that in the phase 1 study, PF-07321332 exceeded the level predicted to inhibit coronavirus viral replication by more than fivefold. Dolsten also stated that the experimental protease inhibitor showed powerful antiviral activity in preclinical testing that could be effective against \"all currently known COVID-19 variants.\"\nSo far, the experimental antiviral drug appears to have a good safety profile. Dolsten said that there haven't been any safety issues in giving doses of up to 500 milligrams twice per day over a 10-day period.\nBased on these encouraging results, Pfizer advanced the oral protease inhibitor into phase 2/3 testing in July. The company will evaluate PF-07321332 in five-day and 10-day treatments for individuals who have been in close contact with someone with COVID-19.\nA big market opportunity\nPfizer estimates that the addressable market for its protease inhibitor could be in the hundreds of millions of patients. That doesn't seem farfetched considering the rapid spread of COVID-19 exposure due to the delta variant.\nThe U.S. Food and Drug Administration (FDA) has already granted Emergency Use Authorization (EUA) to Regeneron's (NASDAQ:REGN) antibody cocktail REGEN-COV as a treatment for hospitalized COVID-19 patients and for post-exposure prophylaxis. However, there are a few drawbacks to Regeneron's therapy.\nFirst, REGEN-COV is expensive -- more than $2,000 per dose. Second, it must be administered via infusion or subcutaneous injection. Third, the current U.S. EUA for post-exposure prophylaxis only applies to individuals who have been exposed to COVID-19 who have a high risk of developing COVID-19 and who haven't been fully vaccinated.\nPfizer's PF-07321332 would be much more convenient than REGEN-COV since it's taken orally. Although the big drugmaker hasn't given any hints about what the pricing for the antiviral therapy might be should it win EUA or approval, a lower price tag could open up a wide market that might include lower-risk individuals who are exposed to COVID-19.\nComing soon?\nThere shouldn't be a long wait for Pfizer's next potential COVID-19 blockbuster. Assuming the phase 2/3 testing goes well, the company thinks that it will be able to file for U.S. EUA in the fourth quarter of this year.\nPfizer CEO Albert Bourla said in the company's Q2 call that he's given the green light to manufacture \"significant quantities\" of the oral protease inhibitor so that large volumes of doses will be available if EUA is granted. He added that Pfizer is absorbing the risk of making this investment because \"it is the right thing to do.\"\nPF-07321332 probably won't be as big a catalyst for the big pharma stock as the Pfizer-BioNTech COVID-19 vaccine. However, Pfizer won't have to split the profits on the oral therapy as it does with BNT162b2. If the company's late-stage testing of the COVID-19 drug is successful, Pfizer seems very likely to have another blockbuster on its hands in 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806620151,"gmtCreate":1627654187873,"gmtModify":1631884384721,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>wwowoww drop till no where???","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>wwowoww drop till no where???","text":"$Atossa Genetics(ATOS)$wwowoww drop till no where???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806620151","isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803066783,"gmtCreate":1627396914742,"gmtModify":1631884384746,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>rubbish sia","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>rubbish sia","text":"$Atossa Genetics(ATOS)$rubbish sia","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/803066783","isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175708298,"gmtCreate":1627048357214,"gmtModify":1631889848662,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/175708298","repostId":"175285338","repostType":1,"repost":{"id":175285338,"gmtCreate":1627034771524,"gmtModify":1631884384799,"author":{"id":"3576993112269247","authorId":"3576993112269247","name":"Gold75","avatar":"https://static.tigerbbs.com/3e12eb0f20c1c6eecc3de5d5be4a1184","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576993112269247","authorIdStr":"3576993112269247"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>up up up&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>up up up&nbsp;","text":"$Atossa Genetics(ATOS)$up up up","images":[{"img":"https://static.tigerbbs.com/b5110af379c7329900a9e2715089e74c","width":"1242","height":"1767"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/175285338","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175701957,"gmtCreate":1627048312379,"gmtModify":1631889848674,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/175701957","repostId":"1189107355","repostType":4,"repost":{"id":"1189107355","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627048116,"share":"https://www.laohu8.com/m/news/1189107355?lang=&edition=full","pubTime":"2021-07-23 21:48","market":"us","language":"en","title":"EV stocks fell in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1189107355","media":"Tiger Newspress","summary":" EV stocks fell in morning trading.NIO fell over 4% in morning trading. Share of Nio Inc. $$ shed over 4% in morning trading Friday, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of","content":"<p>(July 23)&nbsp;EV stocks fell in morning trading.<img src=\"https://static.tigerbbs.com/f45ffb8434a296f7bba1b10ac9e9b88f\" tg-width=\"374\" tg-height=\"206\" width=\"100%\" height=\"auto\"><b>NIO</b>&nbsp;<b>fell</b>&nbsp;<b>over&nbsp;4% in morning trading</b></p>\n<ul>\n <li><b>Share of Nio Inc. <a href=\"https://laohu8.com/S/NIO\">$(NIO)$</a> shed over&nbsp;4% in morning trading Friday</b>, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.</li>\n <li>In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07.</li>\n <li>The company said it will not receive any proceeds from the offering.</li>\n <li>The stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> have declined 8.0%, the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> China ETF <a href=\"https://laohu8.com/S/MCHI\">$(MCHI)$</a> has slipped 4.3% and the S&amp;P 500 has gained 16.3%.</li>\n</ul>\n<p><b><b>Tesla</b></b><b>&nbsp;fell&nbsp;0.87%&nbsp;in morning trading</b></p>\n<ul>\n <li><b>T</b><b>esla Inc</b>TSLA 0.8%has once again hiked the prices of some of its Model 3 and Model Y vehicles in the United States.</li>\n <li><b>What Happened:</b>The<b>Elon Musk</b>-led company’s latest price hike is a steep $1,000 for the Long Range editions of both Model 3 and Model Y, as per the company’s website.</li>\n <li><b>The Price Hike:</b>The Model 3 Long Range price now starts at $49,990 and the Model Y Long Range at $53,990.</li>\n <li>The estimated delivery time for Model 3 Long Range is 10 to 16 weeks, while for Model Y LR the company website doesn't give any estimated delivery time.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks fell in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks fell in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-23 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(July 23)&nbsp;EV stocks fell in morning trading.<img src=\"https://static.tigerbbs.com/f45ffb8434a296f7bba1b10ac9e9b88f\" tg-width=\"374\" tg-height=\"206\" width=\"100%\" height=\"auto\"><b>NIO</b>&nbsp;<b>fell</b>&nbsp;<b>over&nbsp;4% in morning trading</b></p>\n<ul>\n <li><b>Share of Nio Inc. <a href=\"https://laohu8.com/S/NIO\">$(NIO)$</a> shed over&nbsp;4% in morning trading Friday</b>, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.</li>\n <li>In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07.</li>\n <li>The company said it will not receive any proceeds from the offering.</li>\n <li>The stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> have declined 8.0%, the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> China ETF <a href=\"https://laohu8.com/S/MCHI\">$(MCHI)$</a> has slipped 4.3% and the S&amp;P 500 has gained 16.3%.</li>\n</ul>\n<p><b><b>Tesla</b></b><b>&nbsp;fell&nbsp;0.87%&nbsp;in morning trading</b></p>\n<ul>\n <li><b>T</b><b>esla Inc</b>TSLA 0.8%has once again hiked the prices of some of its Model 3 and Model Y vehicles in the United States.</li>\n <li><b>What Happened:</b>The<b>Elon Musk</b>-led company’s latest price hike is a steep $1,000 for the Long Range editions of both Model 3 and Model Y, as per the company’s website.</li>\n <li><b>The Price Hike:</b>The Model 3 Long Range price now starts at $49,990 and the Model Y Long Range at $53,990.</li>\n <li>The estimated delivery time for Model 3 Long Range is 10 to 16 weeks, while for Model Y LR the company website doesn't give any estimated delivery time.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189107355","content_text":"(July 23) EV stocks fell in morning trading.NIO fell over 4% in morning trading\n\nShare of Nio Inc. $(NIO)$ shed over 4% in morning trading Friday, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.\nIn and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07.\nThe company said it will not receive any proceeds from the offering.\nThe stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. $(TSLA)$ have declined 8.0%, the iShares MSCI China ETF $(MCHI)$ has slipped 4.3% and the S&P 500 has gained 16.3%.\n\nTesla fell 0.87% in morning trading\n\nTesla IncTSLA 0.8%has once again hiked the prices of some of its Model 3 and Model Y vehicles in the United States.\nWhat Happened:TheElon Musk-led company’s latest price hike is a steep $1,000 for the Long Range editions of both Model 3 and Model Y, as per the company’s website.\nThe Price Hike:The Model 3 Long Range price now starts at $49,990 and the Model Y Long Range at $53,990.\nThe estimated delivery time for Model 3 Long Range is 10 to 16 weeks, while for Model Y LR the company website doesn't give any estimated delivery time.","news_type":1},"isVote":1,"tweetType":1,"viewCount":87,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178807240,"gmtCreate":1626795100880,"gmtModify":1631889848685,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/178807240","repostId":"1109861258","repostType":4,"repost":{"id":"1109861258","kind":"news","pubTimestamp":1626793354,"share":"https://www.laohu8.com/m/news/1109861258?lang=&edition=full","pubTime":"2021-07-20 23:02","market":"us","language":"en","title":"Behind The Plunge In Yields: This Is A Growth Story, Not A Rethink Of Inflation","url":"https://stock-news.laohu8.com/highlight/detail?id=1109861258","media":"zerohedge","summary":"In a notable turn of events, the overnight session saw an initial attempt at a modest reversal in th","content":"<p>In a notable turn of events, the overnight session saw an initial attempt at a modest reversal in the recent Treasury rally only to be met with further buying interest. The net result was a tick lower in 10-year yields that brought the benchmark to levels not seen since mid-February.</p>\n<p><img src=\"https://static.tigerbbs.com/48f958db8d2903a76ff6541648b287fc\" tg-width=\"1223\" tg-height=\"687\" width=\"100%\" height=\"auto\">With the next technical target sill 5 bps away, we’ll be watching the interplay between risk assets and US rates as the delta-inspired repricing continues. We’re cognizant that the severity of the recent move has led to stretched momentum measures, implying incremental gains will be more difficult to achieve. This isn’t to suggest the floor for rates is evident at the moment, rather that it should be anticipated that the pace of the rally will slow.<b>There has been plenty of chatter surrounding the possibility 10- year yields dip below 1.0%; an eventuality that would be a short-lived endeavor, but not one that’s off the table.</b>More immediately however, will be gauging the extent to which rising case counts can carry yields even lower from here.</p>\n<p><b>It would be an oversimplification to conclude this move is entirely a function of the economic risks posed by the reinstatement of covid-19 restrictions. In fact, we’ll argue the rally has been exaggerated by the Fed’s most recent efforts to be less dovish.</b>Policymakers are in the pre-meeting radio period of radio silence; which eliminates the potential for any official commentary on the Fed’s take on the renewed pandemic risks. Moreover,<b>it leaves investors operating under the assumption that 1) tapering is still on track, 2) rate hikes as early as next year could come to fruition, and 3) the Fed’s ‘will act if not transitory’ stance on inflation remains value</b>. While these surely still hold true to some extent, the implied commitment may be waning given investors’ response to the recent covid developments.</p>\n<p>Headlines this morning conclude ‘markets no longer worried about inflation’; a notion, which is ostensibly consistent with the price action in US rates, misses the mark.<b>10-year breakevens are still at 225 bp and a distance away from the mid-June lows.</b>In addition, rising supply-driven inflation that functions as a tax on consumption as opposed to a reflection of a healthy real economy creates downside risks for the recovery. When combined with concerns that H1 will represent the peak of the rebound, it follows intuitively that the market has moved on to trading the next stage in the cycle – i.e. recalibrating growth expectations in reflecting the new norm; one in which herd immunity will prove elusive and variant risks (delta and others) become an ongoing concern.<b>A quick glance at real yields near -100 bp reinforces the read that this is a growth story, not a collective rethink of reflation.</b></p>\n<p>There is yet another nuance of the price action that merits highlighting. Specifically, the move thus far has questionably been a flattening event as 10s and 30s outperform. The front end of the curve has benefited to a lesser extent as monetary policy expectations have remained in place.<b>This morning however, we’re starting to see the 5-year sector lead the rally. In the event we’re seeing the transition from a longer-term growth story to further pricing out Fed tightening, this could ultimately serve to moderate the gains in 10s and 30s.</b>This isn’t to suggest that less room for the FOMC to eventually normalize policy rates is a compelling reason to sell duration in the face of a resurgence of the pandemic. Instead, confidence that monetary policymakers won’t be so eager to respond to pockets of reflation given the renewed headwinds facing the global recovery</p>\n<p>We’ll be tracking this particular evolution in the nature of the bullish repricing if, for no other reason,<b>it will be instrumental in gauging what to anticipate in response to next week’s FOMC meeting and Powell’s press conference.</b>Note that in light of the +8.1% consensus estimate for next week’s release of Q2 real GDP, there is little question that a strong rebound in H1 is priced in and investors have shifted toward trading the next stage in the recovery that contains far greater uncertainties.</p>\n<p>If the move in real yields is any indication there is growing angst on the rebound; 10-year real rates reached their lowest level since early January and within striking distance of the cycle low at -112.4 bp.</p>\n<p><img src=\"https://static.tigerbbs.com/add9a9864bc513a7f99d365620818f07\" tg-width=\"1223\" tg-height=\"687\" width=\"100%\" height=\"auto\">The decline in reals is made all the more noteworthy given the proximity to Thursday’s $16 bn new issue 10-year TIPS auction. Current valuations demonstrate not only increasing worry on the spread of the delta variant domestically, but perhaps more consequentially, overseas. Whereas there was once a time when the US rates landscape was solely dictated by the domestic fundamentals, the globalization of the economy and markets now leave Treasury yields a function of the global backdrop. This helps account for the impressive round of bullishness and durability of the bid for USTs even as the data has generally continued to perform well. We’re reminded of the time tested adage that resistance hardly holds on the third attempt, and will monitor the -112 bp line in the sand in 10-year real yields over the balance of the week.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Behind The Plunge In Yields: This Is A Growth Story, Not A Rethink Of Inflation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBehind The Plunge In Yields: This Is A Growth Story, Not A Rethink Of Inflation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 23:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/behind-plunge-yields-growth-story-not-rethink-inflation?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In a notable turn of events, the overnight session saw an initial attempt at a modest reversal in the recent Treasury rally only to be met with further buying interest. The net result was a tick lower...</p>\n\n<a href=\"https://www.zerohedge.com/markets/behind-plunge-yields-growth-story-not-rethink-inflation?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.zerohedge.com/markets/behind-plunge-yields-growth-story-not-rethink-inflation?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109861258","content_text":"In a notable turn of events, the overnight session saw an initial attempt at a modest reversal in the recent Treasury rally only to be met with further buying interest. The net result was a tick lower in 10-year yields that brought the benchmark to levels not seen since mid-February.\nWith the next technical target sill 5 bps away, we’ll be watching the interplay between risk assets and US rates as the delta-inspired repricing continues. We’re cognizant that the severity of the recent move has led to stretched momentum measures, implying incremental gains will be more difficult to achieve. This isn’t to suggest the floor for rates is evident at the moment, rather that it should be anticipated that the pace of the rally will slow.There has been plenty of chatter surrounding the possibility 10- year yields dip below 1.0%; an eventuality that would be a short-lived endeavor, but not one that’s off the table.More immediately however, will be gauging the extent to which rising case counts can carry yields even lower from here.\nIt would be an oversimplification to conclude this move is entirely a function of the economic risks posed by the reinstatement of covid-19 restrictions. In fact, we’ll argue the rally has been exaggerated by the Fed’s most recent efforts to be less dovish.Policymakers are in the pre-meeting radio period of radio silence; which eliminates the potential for any official commentary on the Fed’s take on the renewed pandemic risks. Moreover,it leaves investors operating under the assumption that 1) tapering is still on track, 2) rate hikes as early as next year could come to fruition, and 3) the Fed’s ‘will act if not transitory’ stance on inflation remains value. While these surely still hold true to some extent, the implied commitment may be waning given investors’ response to the recent covid developments.\nHeadlines this morning conclude ‘markets no longer worried about inflation’; a notion, which is ostensibly consistent with the price action in US rates, misses the mark.10-year breakevens are still at 225 bp and a distance away from the mid-June lows.In addition, rising supply-driven inflation that functions as a tax on consumption as opposed to a reflection of a healthy real economy creates downside risks for the recovery. When combined with concerns that H1 will represent the peak of the rebound, it follows intuitively that the market has moved on to trading the next stage in the cycle – i.e. recalibrating growth expectations in reflecting the new norm; one in which herd immunity will prove elusive and variant risks (delta and others) become an ongoing concern.A quick glance at real yields near -100 bp reinforces the read that this is a growth story, not a collective rethink of reflation.\nThere is yet another nuance of the price action that merits highlighting. Specifically, the move thus far has questionably been a flattening event as 10s and 30s outperform. The front end of the curve has benefited to a lesser extent as monetary policy expectations have remained in place.This morning however, we’re starting to see the 5-year sector lead the rally. In the event we’re seeing the transition from a longer-term growth story to further pricing out Fed tightening, this could ultimately serve to moderate the gains in 10s and 30s.This isn’t to suggest that less room for the FOMC to eventually normalize policy rates is a compelling reason to sell duration in the face of a resurgence of the pandemic. Instead, confidence that monetary policymakers won’t be so eager to respond to pockets of reflation given the renewed headwinds facing the global recovery\nWe’ll be tracking this particular evolution in the nature of the bullish repricing if, for no other reason,it will be instrumental in gauging what to anticipate in response to next week’s FOMC meeting and Powell’s press conference.Note that in light of the +8.1% consensus estimate for next week’s release of Q2 real GDP, there is little question that a strong rebound in H1 is priced in and investors have shifted toward trading the next stage in the recovery that contains far greater uncertainties.\nIf the move in real yields is any indication there is growing angst on the rebound; 10-year real rates reached their lowest level since early January and within striking distance of the cycle low at -112.4 bp.\nThe decline in reals is made all the more noteworthy given the proximity to Thursday’s $16 bn new issue 10-year TIPS auction. Current valuations demonstrate not only increasing worry on the spread of the delta variant domestically, but perhaps more consequentially, overseas. Whereas there was once a time when the US rates landscape was solely dictated by the domestic fundamentals, the globalization of the economy and markets now leave Treasury yields a function of the global backdrop. This helps account for the impressive round of bullishness and durability of the bid for USTs even as the data has generally continued to perform well. We’re reminded of the time tested adage that resistance hardly holds on the third attempt, and will monitor the -112 bp line in the sand in 10-year real yields over the balance of the week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170401838,"gmtCreate":1626444441424,"gmtModify":1631884384877,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>what the. Why????","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>what the. Why????","text":"$Atossa Genetics(ATOS)$what the. Why????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170401838","isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142063947,"gmtCreate":1626104513289,"gmtModify":1631884025320,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>wow","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>wow","text":"$Exela Technologies, Inc.(XELA)$wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142063947","isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":102380394,"gmtCreate":1620177564418,"gmtModify":1631886667919,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/A17U.SI\">$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$</a>why drop so much???&nbsp;","listText":"<a href=\"https://laohu8.com/S/A17U.SI\">$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$</a>why drop so much???&nbsp;","text":"$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$why drop so much???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/102380394","isVote":1,"tweetType":1,"viewCount":2541,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":388423907,"gmtCreate":1613086644509,"gmtModify":1634554585910,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>我在$4，稳住。","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>我在$4，稳住。","text":"$Sundial Growers Inc.(SNDL)$我在$4，稳住。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/388423907","isVote":1,"tweetType":1,"viewCount":448,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":368398941,"gmtCreate":1614283959983,"gmtModify":1703475822811,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>still looking good :) wait for u 🤑🤑","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>still looking good :) wait for u 🤑🤑","text":"$Sundial Growers Inc.(SNDL)$still looking good :) wait for u 🤑🤑","images":[{"img":"https://static.tigerbbs.com/328b36fbe1338cd720beb37ff1c7e788","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/368398941","isVote":1,"tweetType":1,"viewCount":1397,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":875738339,"gmtCreate":1637684321842,"gmtModify":1637684321966,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>when is result coming out?","listText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>when is result coming out?","text":"$Senseonics(SENS)$when is result coming out?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875738339","isVote":1,"tweetType":1,"viewCount":2467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":125099075,"gmtCreate":1624635599797,"gmtModify":1631888971323,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PIRS\">$Pieris Pharmaceuticals(PIRS)$</a>where are u going again.......","listText":"<a href=\"https://laohu8.com/S/PIRS\">$Pieris Pharmaceuticals(PIRS)$</a>where are u going again.......","text":"$Pieris Pharmaceuticals(PIRS)$where are u going again.......","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/125099075","isVote":1,"tweetType":1,"viewCount":707,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142063947,"gmtCreate":1626104513289,"gmtModify":1631884025320,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>wow","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>wow","text":"$Exela Technologies, Inc.(XELA)$wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142063947","isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":344685193,"gmtCreate":1618406483512,"gmtModify":1631883800521,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/U\">$Unity Software Inc.(U)$</a>need a comment and a like please","listText":"<a href=\"https://laohu8.com/S/U\">$Unity Software Inc.(U)$</a>need a comment and a like please","text":"$Unity Software Inc.(U)$need a comment and a like please","images":[{"img":"https://static.tigerbbs.com/9ea45a5389cdc5549aa8aa7028b9d49c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/344685193","isVote":1,"tweetType":1,"viewCount":575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":346371703,"gmtCreate":1618009443402,"gmtModify":1634295302560,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"Oh please like","listText":"Oh please like","text":"Oh please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/346371703","repostId":"1168300924","repostType":4,"repost":{"id":"1168300924","kind":"news","pubTimestamp":1617955250,"share":"https://www.laohu8.com/m/news/1168300924?lang=&edition=full","pubTime":"2021-04-09 16:00","market":"us","language":"en","title":"Next Week’s IPO Lineup Is Growing. It Could Be Busy.","url":"https://stock-news.laohu8.com/highlight/detail?id=1168300924","media":"barrons","summary":"The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.And Alkami Technology,a bank software company, and Karat Pa","content":"<p>The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.</p><p>Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.</p><p>And Alkami Technology,a bank software company, and Karat Packaging, whichmakes environmentally-friendly disposable food service products, are also reportedly going public.</p><p>This week, by way of contrast, two companies, Reneo Pharmaceuticals and VectivBio Holding, are listing. Both are small biotech companies that areslated to begin trading on the Nasdaq on Friday.</p><p>Applovin on Wednesday set terms for its initial public offering. It is offering 25 million shares at $75 to $85 each, which means it could raise as much as $2.13 billion if the stock sells at the high end of that range. The company plans to trade on the Nasdaq under the symbol APP.</p><p>Eighteen underwriters are listed in the Applovin prospectus, includingMorgan Stanley(ticker: MS),JPMorgan Chase(JPM),KKR,&nbsp;Bank of America‘s (BAC) BofA Securities, andCitigroup(C).</p><p>Founded in 2012, Applovin&nbsp;provides software&nbsp;used by mobile-game developers to grow their businesses.&nbsp; Some 410 million people a day open apps that contain Applovin software, according to the company. Applovin also has a portfolio of more than 200 free-to-play mobile games with 32 million daily users.</p><p>In 2018, KKRbought a minority stakein Applovin for $400 million, valuing Applovin at $2 billion at the time. Applovin in February acquired Adjust, a firm that helps mobile-app developers measure the performance of apps and prevent fraud, for $1 billion. KKR will own 67.4% of the company after the IPO, theprospectus said.</p><p>With 357,955,309 shares outstanding, Applovin’s market capitalization could hit $30 billion.</p><p>TuSimple also set terms for its IPO. The self-driving technology company could raise as much as $1.3 billion; it is offering nearly 34 million shares at $35 to $39 each. It will trade on the Nasdaq under the ticker TSP.</p><p>Morgan Stanley(MS),Citigroup,and J.P. Morgan (JPM) are lead bookrunners on the deal.</p><p>Founded in 2015, TuSimple is looking to transform the $800 billion trucking industry. The San Diego company, which has plants in Tucson, Shanghai, and Beijing, in addition to operations in Japan, is developing an autonomous freight network for long-haul, semi-trucks that it says will increase efficiency and safety on the road, while cutting operating costs.</p><p>TuSimple develops software for the Level 4 self-driving, long-haul trucks, which can see up to 1,000 meters away, equivalent to 30 seconds of driving time. High-definition maps provide accuracy within five centimeters.</p><p>The company is partnering withNavistar(NAV) to develop trucks for the North American market by 2024,its prospectus said. TuSimple has another partnership withVolkswagensubsidiary TRATON for trucks in Europe. Navistar, TRATON, and United Parcel Service (UPS) are all investors.</p><p>TuSimple has raised $800 million in funding, including a $350 million round in November led by VectoIQ.BlackRock(BR), Fidelity Management &amp; Research Co and Capital Group are in talks to buy up to 10.1 million TuSimple shares at the IPO price, the prospectus said.</p><p>The company will have 212,263,328 shares outstanding, meaning TuSimple’s market cap could climb to $8.3 billion. TuSimple, however, is not profitable. Losses widened to $177.9 million in 2020 from $84.9 million in 2019. Revenue jumped nearly 160% to $1.8 million in 2020.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Next Week’s IPO Lineup Is Growing. It Could Be Busy.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNext Week’s IPO Lineup Is Growing. It Could Be Busy.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 16:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2><strong>barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six....</p>\n\n<a href=\"https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VECT":"VectivBio Holding AG","COIN":"Coinbase Global, Inc.","ALKT":"Alkami Technology, Inc.","APP":"AppLovin Corporation","KRT":"Karat Packaging Inc."},"source_url":"https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168300924","content_text":"The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.And Alkami Technology,a bank software company, and Karat Packaging, whichmakes environmentally-friendly disposable food service products, are also reportedly going public.This week, by way of contrast, two companies, Reneo Pharmaceuticals and VectivBio Holding, are listing. Both are small biotech companies that areslated to begin trading on the Nasdaq on Friday.Applovin on Wednesday set terms for its initial public offering. It is offering 25 million shares at $75 to $85 each, which means it could raise as much as $2.13 billion if the stock sells at the high end of that range. The company plans to trade on the Nasdaq under the symbol APP.Eighteen underwriters are listed in the Applovin prospectus, includingMorgan Stanley(ticker: MS),JPMorgan Chase(JPM),KKR, Bank of America‘s (BAC) BofA Securities, andCitigroup(C).Founded in 2012, Applovin provides software used by mobile-game developers to grow their businesses.  Some 410 million people a day open apps that contain Applovin software, according to the company. Applovin also has a portfolio of more than 200 free-to-play mobile games with 32 million daily users.In 2018, KKRbought a minority stakein Applovin for $400 million, valuing Applovin at $2 billion at the time. Applovin in February acquired Adjust, a firm that helps mobile-app developers measure the performance of apps and prevent fraud, for $1 billion. KKR will own 67.4% of the company after the IPO, theprospectus said.With 357,955,309 shares outstanding, Applovin’s market capitalization could hit $30 billion.TuSimple also set terms for its IPO. The self-driving technology company could raise as much as $1.3 billion; it is offering nearly 34 million shares at $35 to $39 each. It will trade on the Nasdaq under the ticker TSP.Morgan Stanley(MS),Citigroup,and J.P. Morgan (JPM) are lead bookrunners on the deal.Founded in 2015, TuSimple is looking to transform the $800 billion trucking industry. The San Diego company, which has plants in Tucson, Shanghai, and Beijing, in addition to operations in Japan, is developing an autonomous freight network for long-haul, semi-trucks that it says will increase efficiency and safety on the road, while cutting operating costs.TuSimple develops software for the Level 4 self-driving, long-haul trucks, which can see up to 1,000 meters away, equivalent to 30 seconds of driving time. High-definition maps provide accuracy within five centimeters.The company is partnering withNavistar(NAV) to develop trucks for the North American market by 2024,its prospectus said. TuSimple has another partnership withVolkswagensubsidiary TRATON for trucks in Europe. Navistar, TRATON, and United Parcel Service (UPS) are all investors.TuSimple has raised $800 million in funding, including a $350 million round in November led by VectoIQ.BlackRock(BR), Fidelity Management & Research Co and Capital Group are in talks to buy up to 10.1 million TuSimple shares at the IPO price, the prospectus said.The company will have 212,263,328 shares outstanding, meaning TuSimple’s market cap could climb to $8.3 billion. TuSimple, however, is not profitable. Losses widened to $177.9 million in 2020 from $84.9 million in 2019. Revenue jumped nearly 160% to $1.8 million in 2020.","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168510571,"gmtCreate":1623978425993,"gmtModify":1631888415254,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>where are you going. Alamak","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>where are you going. Alamak","text":"$KEPPEL DC REIT(AJBU.SI)$where are you going. Alamak","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/168510571","isVote":1,"tweetType":1,"viewCount":367,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":118468356,"gmtCreate":1622755159875,"gmtModify":1631885010329,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>finally. Come&nbsp;","listText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>finally. Come&nbsp;","text":"$Senseonics(SENS)$finally. Come","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/118468356","isVote":1,"tweetType":1,"viewCount":736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":383602789,"gmtCreate":1612870188941,"gmtModify":1703766052042,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>wow it keep dropping, is it normal?","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>wow it keep dropping, is it normal?","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$wow it keep dropping, is it normal?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/383602789","isVote":1,"tweetType":1,"viewCount":2838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806620151,"gmtCreate":1627654187873,"gmtModify":1631884384721,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>wwowoww drop till no where???","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>wwowoww drop till no where???","text":"$Atossa Genetics(ATOS)$wwowoww drop till no where???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806620151","isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175701957,"gmtCreate":1627048312379,"gmtModify":1631889848674,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/175701957","repostId":"1189107355","repostType":4,"repost":{"id":"1189107355","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627048116,"share":"https://www.laohu8.com/m/news/1189107355?lang=&edition=full","pubTime":"2021-07-23 21:48","market":"us","language":"en","title":"EV stocks fell in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1189107355","media":"Tiger Newspress","summary":" EV stocks fell in morning trading.NIO fell over 4% in morning trading. Share of Nio Inc. $$ shed over 4% in morning trading Friday, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of","content":"<p>(July 23)&nbsp;EV stocks fell in morning trading.<img src=\"https://static.tigerbbs.com/f45ffb8434a296f7bba1b10ac9e9b88f\" tg-width=\"374\" tg-height=\"206\" width=\"100%\" height=\"auto\"><b>NIO</b>&nbsp;<b>fell</b>&nbsp;<b>over&nbsp;4% in morning trading</b></p>\n<ul>\n <li><b>Share of Nio Inc. <a href=\"https://laohu8.com/S/NIO\">$(NIO)$</a> shed over&nbsp;4% in morning trading Friday</b>, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.</li>\n <li>In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07.</li>\n <li>The company said it will not receive any proceeds from the offering.</li>\n <li>The stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> have declined 8.0%, the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> China ETF <a href=\"https://laohu8.com/S/MCHI\">$(MCHI)$</a> has slipped 4.3% and the S&amp;P 500 has gained 16.3%.</li>\n</ul>\n<p><b><b>Tesla</b></b><b>&nbsp;fell&nbsp;0.87%&nbsp;in morning trading</b></p>\n<ul>\n <li><b>T</b><b>esla Inc</b>TSLA 0.8%has once again hiked the prices of some of its Model 3 and Model Y vehicles in the United States.</li>\n <li><b>What Happened:</b>The<b>Elon Musk</b>-led company’s latest price hike is a steep $1,000 for the Long Range editions of both Model 3 and Model Y, as per the company’s website.</li>\n <li><b>The Price Hike:</b>The Model 3 Long Range price now starts at $49,990 and the Model Y Long Range at $53,990.</li>\n <li>The estimated delivery time for Model 3 Long Range is 10 to 16 weeks, while for Model Y LR the company website doesn't give any estimated delivery time.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks fell in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks fell in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-23 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(July 23)&nbsp;EV stocks fell in morning trading.<img src=\"https://static.tigerbbs.com/f45ffb8434a296f7bba1b10ac9e9b88f\" tg-width=\"374\" tg-height=\"206\" width=\"100%\" height=\"auto\"><b>NIO</b>&nbsp;<b>fell</b>&nbsp;<b>over&nbsp;4% in morning trading</b></p>\n<ul>\n <li><b>Share of Nio Inc. <a href=\"https://laohu8.com/S/NIO\">$(NIO)$</a> shed over&nbsp;4% in morning trading Friday</b>, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.</li>\n <li>In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07.</li>\n <li>The company said it will not receive any proceeds from the offering.</li>\n <li>The stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> have declined 8.0%, the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> China ETF <a href=\"https://laohu8.com/S/MCHI\">$(MCHI)$</a> has slipped 4.3% and the S&amp;P 500 has gained 16.3%.</li>\n</ul>\n<p><b><b>Tesla</b></b><b>&nbsp;fell&nbsp;0.87%&nbsp;in morning trading</b></p>\n<ul>\n <li><b>T</b><b>esla Inc</b>TSLA 0.8%has once again hiked the prices of some of its Model 3 and Model Y vehicles in the United States.</li>\n <li><b>What Happened:</b>The<b>Elon Musk</b>-led company’s latest price hike is a steep $1,000 for the Long Range editions of both Model 3 and Model Y, as per the company’s website.</li>\n <li><b>The Price Hike:</b>The Model 3 Long Range price now starts at $49,990 and the Model Y Long Range at $53,990.</li>\n <li>The estimated delivery time for Model 3 Long Range is 10 to 16 weeks, while for Model Y LR the company website doesn't give any estimated delivery time.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189107355","content_text":"(July 23) EV stocks fell in morning trading.NIO fell over 4% in morning trading\n\nShare of Nio Inc. $(NIO)$ shed over 4% in morning trading Friday, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.\nIn and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07.\nThe company said it will not receive any proceeds from the offering.\nThe stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. $(TSLA)$ have declined 8.0%, the iShares MSCI China ETF $(MCHI)$ has slipped 4.3% and the S&P 500 has gained 16.3%.\n\nTesla fell 0.87% in morning trading\n\nTesla IncTSLA 0.8%has once again hiked the prices of some of its Model 3 and Model Y vehicles in the United States.\nWhat Happened:TheElon Musk-led company’s latest price hike is a steep $1,000 for the Long Range editions of both Model 3 and Model Y, as per the company’s website.\nThe Price Hike:The Model 3 Long Range price now starts at $49,990 and the Model Y Long Range at $53,990.\nThe estimated delivery time for Model 3 Long Range is 10 to 16 weeks, while for Model Y LR the company website doesn't give any estimated delivery time.","news_type":1},"isVote":1,"tweetType":1,"viewCount":87,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127715866,"gmtCreate":1624868916355,"gmtModify":1631884927172,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MMAT\">$Meta Materials Inc.(MMAT)$</a>wow suddenly.&nbsp;","listText":"<a href=\"https://laohu8.com/S/MMAT\">$Meta Materials Inc.(MMAT)$</a>wow suddenly.&nbsp;","text":"$Meta Materials Inc.(MMAT)$wow suddenly.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/127715866","isVote":1,"tweetType":1,"viewCount":461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189959292,"gmtCreate":1623241766316,"gmtModify":1631885010063,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>lets see whether you can maintain and growth anot. Having faith in u.","listText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>lets see whether you can maintain and growth anot. Having faith in u.","text":"$Senseonics(SENS)$lets see whether you can maintain and growth anot. Having faith in u.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/189959292","isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134963968,"gmtCreate":1622201128854,"gmtModify":1631891775102,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/134963968","repostId":"1171341248","repostType":4,"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":105546342,"gmtCreate":1620312961286,"gmtModify":1631887025363,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NOK\">$Nokia Oyj(NOK)$</a>finally after 3 months","listText":"<a href=\"https://laohu8.com/S/NOK\">$Nokia Oyj(NOK)$</a>finally after 3 months","text":"$Nokia Oyj(NOK)$finally after 3 months","images":[{"img":"https://static.tigerbbs.com/331f71a28c15349f841ccc0052f8b789","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/105546342","isVote":1,"tweetType":1,"viewCount":352,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":102311328,"gmtCreate":1620177252064,"gmtModify":1631885598930,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>jiayou","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>jiayou","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$jiayou","images":[{"img":"https://static.tigerbbs.com/bac5c8370a5a4dfb2d9c820b6bdd0834","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/102311328","isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":380876259,"gmtCreate":1612535803071,"gmtModify":1703763284910,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>anyone still holding?","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>anyone still holding?","text":"$AMC Entertainment(AMC)$anyone still holding?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/380876259","isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143786506,"gmtCreate":1625818435405,"gmtModify":1631884358993,"author":{"id":"3571128564126664","authorId":"3571128564126664","name":"smylp","avatar":"https://static.tigerbbs.com/e97caff6f1cb863d58c6113fd9508ca7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571128564126664","authorIdStr":"3571128564126664"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>waiting for u to come down. So I can buy more","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>waiting for u to come down. So I can buy more","text":"$Exela Technologies, Inc.(XELA)$waiting for u to come down. So I can buy more","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/143786506","isVote":1,"tweetType":1,"viewCount":1027,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}